Skip to main content
Erschienen in: Journal of Neurology 2/2018

04.12.2017 | Original Communication

Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim–Chester disease

verfasst von: Luisa Chiapparini, Giulio Cavalli, Tiziana Langella, Anna Venerando, Giacomo De Luca, Sergio Raspante, Giorgio Marotta, Bianca Pollo, Giuseppe Lauria, Maria Giulia Cangi, Simonetta Gerevini, Andrea Botturi, Davide Pareyson, Lorenzo Dagna, Ettore Salsano

Erschienen in: Journal of Neurology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Leukoencephalopathies with prominent involvement of cerebellum and brainstem, henceforward called prominent infratentorial leukoencephalopathies (PILs), encompass a variety of inherited and acquired white matter diseases. Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis likely under-diagnosed as cause of adult PIL.

Methods

We reviewed the clinical and laboratory information of ten consecutive sporadic adult patients with PIL of unknown origin, who were investigated for ECD.

Results

There were seven males and three females; mean age at clinical onset was 49.6 years (range 38–59); cerebellar ataxia with or without other neurological symptoms was the only or the main clinical manifestation; diabetes insipidus was present in three individuals. Eight patients had white matter focal supratentorial abnormalities, in addition to the infratentorial white matter changes. Six out of eight patients had spinal cord lesions. Thoraco-abdominal CT showed periaortic sheathing in two patients, whole-body FDG-PET revealed increased glucose uptake in the long bones of the legs in five patients, brain FDG-PET showed overt infratentorial hypermetabolism in one patient. In eight patients, ECD was confirmed by bone scintigraphy, pathological data, or both. Two ECD patients treated with vemurafenib showed a marked improvement of neurological symptoms and brain MRI abnormalities at 1 year follow-up.

Conclusions

Symptoms of PIL can be the only clinical manifestation of ECD. Adult patients with PIL of unknown origin should undergo investigations aimed at unveiling ECD, including bone scintigraphy and whole-body FDG-PET. The early diagnosis allows starting disease-modifying therapies of an otherwise life-threatening disease.
Literatur
1.
2.
Zurück zum Zitat Gass A, Filippi M, Grossman RI (2000) The contribution of MRI in the differential diagnosis of posterior fossa damage. J NeurolSci 172(Suppl 1):S43–S49 Gass A, Filippi M, Grossman RI (2000) The contribution of MRI in the differential diagnosis of posterior fossa damage. J NeurolSci 172(Suppl 1):S43–S49
3.
Zurück zum Zitat Rovira À, Sastre-Garriga J, Auger C et al (2013) Idiopathic inflammatory demyelinating diseases of the brainstem. Semin Ultrasound CT MR 34:123–130CrossRefPubMed Rovira À, Sastre-Garriga J, Auger C et al (2013) Idiopathic inflammatory demyelinating diseases of the brainstem. Semin Ultrasound CT MR 34:123–130CrossRefPubMed
4.
Zurück zum Zitat Akman-Demir G, Bahar S, Coban O et al (2003) Cranial MRI in Behçet’s disease: 134 examinations of 98 patients. Neuroradiology 45:851–859CrossRefPubMed Akman-Demir G, Bahar S, Coban O et al (2003) Cranial MRI in Behçet’s disease: 134 examinations of 98 patients. Neuroradiology 45:851–859CrossRefPubMed
5.
Zurück zum Zitat Pittock SJ, Debruyne J, Krecke KN et al (2010) Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 133:2626–2634CrossRefPubMed Pittock SJ, Debruyne J, Krecke KN et al (2010) Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 133:2626–2634CrossRefPubMed
6.
Zurück zum Zitat Tateishi U, Terae S, Ogata A et al (2001) MR imaging of the brain in lymphomatoidgranulomatosis. AJNR Am J Neuroradiol 22:1283–1290PubMed Tateishi U, Terae S, Ogata A et al (2001) MR imaging of the brain in lymphomatoidgranulomatosis. AJNR Am J Neuroradiol 22:1283–1290PubMed
7.
Zurück zum Zitat Landolfi JC, Thaler HT, DeAngelis LM (1998) Adult brainstem gliomas. Neurology 51:1136–1139CrossRefPubMed Landolfi JC, Thaler HT, DeAngelis LM (1998) Adult brainstem gliomas. Neurology 51:1136–1139CrossRefPubMed
8.
9.
Zurück zum Zitat Singh TD, Fugate JE, Rabinstein AA (2014) Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol 21:1443–1450CrossRefPubMed Singh TD, Fugate JE, Rabinstein AA (2014) Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol 21:1443–1450CrossRefPubMed
10.
Zurück zum Zitat van der Knaap MS, Arts WF, Garbern JY et al (2008) Cerebellar leukoencephalopathy: most likely histiocytosis-related. Neurology 71:1361–1367CrossRefPubMed van der Knaap MS, Arts WF, Garbern JY et al (2008) Cerebellar leukoencephalopathy: most likely histiocytosis-related. Neurology 71:1361–1367CrossRefPubMed
11.
Zurück zum Zitat Diamond EL, Dagna L, Hyman DM et al (2014) Consensus guidelines for the diagnosis and clinical management of Erdheim–Chester disease. Blood 124:483–492CrossRefPubMedPubMedCentral Diamond EL, Dagna L, Hyman DM et al (2014) Consensus guidelines for the diagnosis and clinical management of Erdheim–Chester disease. Blood 124:483–492CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Cavalli G, Guglielmi B, Berti A et al (2013) The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis 72:1691–1695CrossRefPubMed Cavalli G, Guglielmi B, Berti A et al (2013) The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis 72:1691–1695CrossRefPubMed
13.
Zurück zum Zitat Salsano E, Savoiardo M, Nappini S et al (2008) Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim–Chester disease. Neurol Sci 29:263–267CrossRefPubMed Salsano E, Savoiardo M, Nappini S et al (2008) Late-onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim–Chester disease. Neurol Sci 29:263–267CrossRefPubMed
14.
Zurück zum Zitat Cangi MG, Biavasco R, Cavalli G et al (2015) BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim–Chester disease. Ann Rheum Dis 74:1596–1602CrossRefPubMed Cangi MG, Biavasco R, Cavalli G et al (2015) BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim–Chester disease. Ann Rheum Dis 74:1596–1602CrossRefPubMed
15.
Zurück zum Zitat Cavalli G, Biavasco R, Borgiani B et al (2014) Oncogene-induced senescence as a new mechanism of disease: the paradigm of Erdheim–Chester disease. Front Immunol 5:281CrossRefPubMedPubMedCentral Cavalli G, Biavasco R, Borgiani B et al (2014) Oncogene-induced senescence as a new mechanism of disease: the paradigm of Erdheim–Chester disease. Front Immunol 5:281CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Arnaud L, Hervier B, Néel A et al (2011) CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim–Chester disease: a multicenter survival analysis of 53 patients. Blood 117:2778–2782CrossRefPubMed Arnaud L, Hervier B, Néel A et al (2011) CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim–Chester disease: a multicenter survival analysis of 53 patients. Blood 117:2778–2782CrossRefPubMed
18.
Zurück zum Zitat Haroche J, Cohen-Aubart F, Emile JF et al (2015) Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim–Chester disease. J Clin Oncol 33:411–418CrossRefPubMed Haroche J, Cohen-Aubart F, Emile JF et al (2015) Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim–Chester disease. J Clin Oncol 33:411–418CrossRefPubMed
19.
Zurück zum Zitat López RF, Báñez IA, Robles MB et al (2017) 18F-FDG PET/CT in Erdheim–Chester disease. Eur J Nucl Med Mol Imaging 44:1247–1248CrossRefPubMed López RF, Báñez IA, Robles MB et al (2017) 18F-FDG PET/CT in Erdheim–Chester disease. Eur J Nucl Med Mol Imaging 44:1247–1248CrossRefPubMed
20.
Zurück zum Zitat Ayrignac X, Boutiere C, Carra-Dalliere C et al (2016) Posterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies. J Neurol 263:2361–2368CrossRefPubMed Ayrignac X, Boutiere C, Carra-Dalliere C et al (2016) Posterior fossa involvement in the diagnosis of adult-onset inherited leukoencephalopathies. J Neurol 263:2361–2368CrossRefPubMed
21.
Zurück zum Zitat Campochiaro C, Tomelleri A, Cavalli G et al (2015) Erdheim–Chester disease. Eur J Intern Med 26:223–229CrossRefPubMed Campochiaro C, Tomelleri A, Cavalli G et al (2015) Erdheim–Chester disease. Eur J Intern Med 26:223–229CrossRefPubMed
22.
Zurück zum Zitat Lachenal F, Cotton F, Desmurs-Clavel H et al (2006) Neurological manifestations and neuroradiological presentation of Erdheim–Chester disease: report of 6 cases and systematic review of the literature. J Neurol 253:1267–1277CrossRefPubMed Lachenal F, Cotton F, Desmurs-Clavel H et al (2006) Neurological manifestations and neuroradiological presentation of Erdheim–Chester disease: report of 6 cases and systematic review of the literature. J Neurol 253:1267–1277CrossRefPubMed
23.
Zurück zum Zitat Bianco F, Iacovelli E, Tinelli E et al (2009) Characteristic brain MRI appearance of Erdheim–Chester disease. Neurology 73:2120–2122CrossRefPubMed Bianco F, Iacovelli E, Tinelli E et al (2009) Characteristic brain MRI appearance of Erdheim–Chester disease. Neurology 73:2120–2122CrossRefPubMed
24.
Zurück zum Zitat Adle-Biassette H, Chetritt J, Bergemer-Fouquet AM et al (1997) Pathology of the central nervous system in Chester-Erdheim disease: report of three cases. J Neuropathol Exp Neurol 56:1207–1216CrossRefPubMed Adle-Biassette H, Chetritt J, Bergemer-Fouquet AM et al (1997) Pathology of the central nervous system in Chester-Erdheim disease: report of three cases. J Neuropathol Exp Neurol 56:1207–1216CrossRefPubMed
25.
Zurück zum Zitat Diamond EL, Hatzoglou V, Patel S et al (2016) Diffuse reduction of cerebral grey matter volumes in Erdheim–Chester disease. Orphanet J Rare Dis 11:109CrossRefPubMedPubMedCentral Diamond EL, Hatzoglou V, Patel S et al (2016) Diffuse reduction of cerebral grey matter volumes in Erdheim–Chester disease. Orphanet J Rare Dis 11:109CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Tien R, Kucharczyk J, Kucharczyk W (1991) MR imaging of the brain in patients with diabetes insipidus. AJNR Am J Neuroradiol 12:533–542PubMed Tien R, Kucharczyk J, Kucharczyk W (1991) MR imaging of the brain in patients with diabetes insipidus. AJNR Am J Neuroradiol 12:533–542PubMed
27.
Zurück zum Zitat Prosch H, Grois N, Bökkerink J et al (2006) Central diabetes insipidus: is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall. Pediatr Blood Cancer 46:363–366CrossRefPubMed Prosch H, Grois N, Bökkerink J et al (2006) Central diabetes insipidus: is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall. Pediatr Blood Cancer 46:363–366CrossRefPubMed
28.
Zurück zum Zitat Drier A, Haroche J, Savatovsky J et al (2010) Cerebral, facial, and orbital involvement in Erdheim–Chester disease: CT and MR imaging findings. Radiology 255:586–594CrossRefPubMed Drier A, Haroche J, Savatovsky J et al (2010) Cerebral, facial, and orbital involvement in Erdheim–Chester disease: CT and MR imaging findings. Radiology 255:586–594CrossRefPubMed
29.
Zurück zum Zitat Grois N, Prayer D, Prosch H et al (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128:829–838CrossRefPubMed Grois N, Prayer D, Prosch H et al (2005) Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128:829–838CrossRefPubMed
30.
Zurück zum Zitat Ferrero E, Corti A, Haroche J et al (2016) Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim–Chester disease. Oncoimmunology 5:e1181244CrossRefPubMedPubMedCentral Ferrero E, Corti A, Haroche J et al (2016) Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim–Chester disease. Oncoimmunology 5:e1181244CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Bargagli E, Maggiorelli C, Rottoli P (2008) Human chitotriosidase: a potential new marker of sarcoidosis severity. Respiration 76:234–238CrossRefPubMed Bargagli E, Maggiorelli C, Rottoli P (2008) Human chitotriosidase: a potential new marker of sarcoidosis severity. Respiration 76:234–238CrossRefPubMed
32.
Zurück zum Zitat Mossetti G, Rendina D, Numis FG et al (2003) Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim–Chester disease. Clin Exp Rheumatol 21:232–236PubMed Mossetti G, Rendina D, Numis FG et al (2003) Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim–Chester disease. Clin Exp Rheumatol 21:232–236PubMed
34.
Zurück zum Zitat Sedrak P, Ketonen L, Hou P et al (2011) Erdheim–Chester disease of the central nervous system: new manifestations of a rare disease. AJNR Am J Neuroradiol 32:2126–2131CrossRefPubMed Sedrak P, Ketonen L, Hou P et al (2011) Erdheim–Chester disease of the central nervous system: new manifestations of a rare disease. AJNR Am J Neuroradiol 32:2126–2131CrossRefPubMed
35.
Zurück zum Zitat Shamburek RD, Brewer HB Jr, Gochuico BR (2001) Erdheim–Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 321:66–75CrossRefPubMed Shamburek RD, Brewer HB Jr, Gochuico BR (2001) Erdheim–Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 321:66–75CrossRefPubMed
36.
Zurück zum Zitat Birnbaum DC, Shields D, Lippe B et al (1989) Idiopathic central diabetes insipidus followed by progressive spastic cerebral ataxia. Report of four cases. Arch Neurol 46:1001–1003CrossRefPubMed Birnbaum DC, Shields D, Lippe B et al (1989) Idiopathic central diabetes insipidus followed by progressive spastic cerebral ataxia. Report of four cases. Arch Neurol 46:1001–1003CrossRefPubMed
Metadaten
Titel
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim–Chester disease
verfasst von
Luisa Chiapparini
Giulio Cavalli
Tiziana Langella
Anna Venerando
Giacomo De Luca
Sergio Raspante
Giorgio Marotta
Bianca Pollo
Giuseppe Lauria
Maria Giulia Cangi
Simonetta Gerevini
Andrea Botturi
Davide Pareyson
Lorenzo Dagna
Ettore Salsano
Publikationsdatum
04.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8692-8

Weitere Artikel der Ausgabe 2/2018

Journal of Neurology 2/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.